Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ICCC
#3453
Immucell Corp
6.4
0
+0.79%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.79%
Monthly Change
+0.63%
6 month change
+4.40%
Cambio anual
+21.67%
Cierres anteriores
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Volumen
3
Markets
Acciones
Atención Sanitaria
ICCC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Noticias
ImmuCell董事将在2026年年度股东大会上卸任,董事会预计将发生变动
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell宣布新高管雇佣协议及期权授予
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
盈利电话会议记录:ImmuCell 2025年第四季度股价走势向好
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell公司报告第四季度销售额为760万美元,将重心转向First Defense
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio